Today: 20 March 2026
Subscribe
Browse Category

TSX:4523 30 August 2025 - 12 January 2026

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio shares fell 17.7% to $6.62 Monday after announcing a licensing deal with Eisai and releasing initial sales data for its lung-cancer drug. Eisai will pay €50 million upfront for rights outside the U.S., China, and Japan, with further milestone payments possible. Fourth-quarter Ibtrozi sales met estimates, but investors appeared cautious on future prescription growth.
12 January 2026
····
Japan Stock Market Today: Nikkei 225 Ends Flat as SoftBank Crashes on AI Jitters – November 25, 2025

Japan Stock Market Today: Nikkei 225 Ends Flat as SoftBank Crashes on AI Jitters – November 25, 2025

SoftBank Group shares plunged 9.95% in Tokyo on Tuesday, erasing most of the Nikkei 225’s early gains and wiping an estimated 338 points from the index. The Nikkei closed up just 0.07% at 48,659.52 after surging more than 1% at the open, while the Topix slipped 0.21%. Turnover on the Topix was above the three-month average.
25 November 2025
·········
Science Shockers: AI-Created Viruses, “Water Worlds” Debunked & More (Sept 19–20, 2025)

Science Shockers: AI-Created Viruses, “Water Worlds” Debunked & More (Sept 19–20, 2025)

Researchers used AI to design the first viruses from scratch, creating bacteriophages that killed drug-resistant bacteria. Scientists solved why smoking affects ulcerative colitis and Crohn’s disease differently, linking it to mouth bacteria. New Alzheimer’s drugs modestly slowed disease in early stages. Wildfire smoke could kill 70,000 Americans annually by 2050, Stanford researchers warned.
20 September 2025
·····
Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

The FDA approved Leqembi IQLIK, the first at-home injectable Alzheimer’s treatment, enabling weekly self-administered doses. U.S. regulators also cleared Sanofi’s Wayrilz, the first BTK inhibitor for chronic immune thrombocytopenia. Cytokinetics’ aficamten outperformed metoprolol in a Phase 3 heart drug trial. WHO warned Gaza has run out of critical medical supplies amid a spike in Guillain-Barré syndrome cases.
30 August 2025
····

Stock Market Today

  • Asia Markets Fall as Iran Conflict Drives Global Risk-Off; Energy Prices Surge
    March 19, 2026, 9:39 PM EDT. Asian markets edged lower following Wall Street losses amid escalating tensions in the Middle East sparked by Iran's attacks on key energy infrastructure. Tehran's strike on Qatar's largest gas plant slashed LNG export capacity by 17% for years, pushing energy prices higher. U.S. natural gas and Brent crude rose over 1%, with gasoline nearing a four-year peak, underscoring supply concerns. Metals saw volatile moves, gold and silver dropping before recovering. Despite market jitters, U.S. President Trump and Israeli Prime Minister Netanyahu signaled restraint, dampening fears of prolonged conflict. A coalition of U.S.-aligned nations pledged to protect key shipping routes, including the Strait of Hormuz. Asian markets showed mixed reactions, with South Korea's Kospi rising, while Australia's S&P/ASX 200 and Hong Kong futures declined. Wall Street indexes closed down modestly after the Federal Reserve held interest rates steady.
Go toTop